However, preliminary studies did not confirm an association between COVID-19 and this deficit [130] or differences between asymptomatic and symptomatic infected patients [141], even if a G6PD deficit was present in more than 30% of infected subjects. This evidence concerns the gene G6PD and COVID-19.